MX2017007597A - Composición para el alivio de la boca seca. - Google Patents

Composición para el alivio de la boca seca.

Info

Publication number
MX2017007597A
MX2017007597A MX2017007597A MX2017007597A MX2017007597A MX 2017007597 A MX2017007597 A MX 2017007597A MX 2017007597 A MX2017007597 A MX 2017007597A MX 2017007597 A MX2017007597 A MX 2017007597A MX 2017007597 A MX2017007597 A MX 2017007597A
Authority
MX
Mexico
Prior art keywords
relief
composition
dry mouth
maintaining
mucosal surface
Prior art date
Application number
MX2017007597A
Other languages
English (en)
Other versions
MX388182B (es
Inventor
E Swanson Jerome
Original Assignee
Elevate Oral Care Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Elevate Oral Care Llc filed Critical Elevate Oral Care Llc
Publication of MX2017007597A publication Critical patent/MX2017007597A/es
Publication of MX388182B publication Critical patent/MX388182B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A61K31/78—Polymers containing oxygen of acrylic acid or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/547—Chelates, e.g. Gd-DOTA or Zinc-amino acid chelates; Chelate-forming compounds, e.g. DOTA or ethylenediamine being covalently linked or complexed to the pharmacologically- or therapeutically-active agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

Una formulación mucoadhesiva que contiene un clatrato incorporado que encierra moléculas de agua provee un medio efectivo para, no solo proveyendo humedad a, y manteniendo la humedad sobre, la superficie de una mucosa, sino también manteniendo una alta concentración de un alcohol de azúcar in situ sobre la superficie de la mucosa por periodos extendidos.
MX2017007597A 2014-12-10 2015-11-20 Composición para el alivio de la boca seca. MX388182B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201462089942P 2014-12-10 2014-12-10
PCT/US2015/061743 WO2016094054A1 (en) 2014-12-10 2015-11-20 Composition for the relief of dry mouth

Publications (2)

Publication Number Publication Date
MX2017007597A true MX2017007597A (es) 2018-03-01
MX388182B MX388182B (es) 2025-03-19

Family

ID=56107939

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017007597A MX388182B (es) 2014-12-10 2015-11-20 Composición para el alivio de la boca seca.

Country Status (9)

Country Link
US (1) US10772908B2 (es)
EP (1) EP3229792B1 (es)
JP (1) JP6783244B2 (es)
AU (1) AU2015361122B2 (es)
CA (1) CA2970146C (es)
ES (1) ES2982077T3 (es)
MX (1) MX388182B (es)
PL (1) PL3229792T3 (es)
WO (1) WO2016094054A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108778346B (zh) 2016-01-10 2022-02-11 斯迈索尼卡股份有限公司 黏度和稳定性经改进的超声凝胶
CN105833278B (zh) * 2016-04-25 2018-05-08 北京嘉安医疗器械科技有限公司 用于治疗口腔干燥和口腔疾病的组合物
US11478435B2 (en) 2017-02-22 2022-10-25 Smilesonica Inc. Artificial saliva, related methods, and uses
US20230414463A1 (en) * 2020-10-15 2023-12-28 Advantage Silver Dental Arrest, Llc A thickened silver diamine fluoride composition

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3970747A (en) 1974-03-11 1976-07-20 Colgate-Palmolive Company Humectant sweetener
US4340583A (en) * 1979-05-23 1982-07-20 J. M. Huber Corporation High fluoride compatibility dentifrice abrasives and compositions
US4997654A (en) 1989-08-14 1991-03-05 Warner-Lambert Company Method for increasing salivation for xerostomia patients
US5496558A (en) * 1993-03-02 1996-03-05 Block Drug Company Inc. Solid form xerostomia product
US5900230A (en) 1997-08-18 1999-05-04 Squigle, Inc. Dental products to treat and prevent periodontal disease
EP1068871A1 (en) 1999-07-07 2001-01-17 Jean-Paul Perraudin Novel methods and medicament for treating infections diseases involving microbial biofilms
US9044500B2 (en) 2004-08-02 2015-06-02 Glaxosmithkline Consumer Healthcare Gmbh & Co Kg Composition for xerostomia
WO2009108713A2 (en) 2008-02-25 2009-09-03 Signum Biosciences, Inc. Topical compositions and methods utilizing peptides containing lipid-modified cysteine-containing peptides
US8735374B2 (en) 2009-07-31 2014-05-27 Intelgenx Corp. Oral mucoadhesive dosage form
JP5433355B2 (ja) 2009-09-16 2014-03-05 サンスター株式会社 口腔用組成物
US8658139B1 (en) * 2010-02-27 2014-02-25 Squigle, Inc. Prevention and treatment of oral diseases
US20130209376A1 (en) 2010-04-14 2013-08-15 Ips Investments Inc. Oral care compositions
PL2585025T3 (pl) 2010-06-23 2015-04-30 Colgate Palmolive Co Kompozycja terapeutyczna doustna
US20120053130A1 (en) * 2010-08-30 2012-03-01 Bristol-Myers Squibb Company Composition for enhancing absorption of a drug and method
MX354210B (es) 2010-12-16 2018-02-16 Celgene Corp Formas farmaceuticas orales de liberacion controlada de farmacos escasamente solubles y los usos de estas.
JP2014501257A (ja) 2010-12-23 2014-01-20 コルゲート・パーモリブ・カンパニー 水性オーラルケア組成物
WO2013044045A1 (en) 2011-09-23 2013-03-28 Emerald Hilton Davis, Llc Self-assembled nano-structure particle and method for preparing
WO2013089734A1 (en) 2011-12-15 2013-06-20 Colgate-Palmolive Company Aqueous oral care compositions
US9724542B2 (en) 2012-10-12 2017-08-08 Premier Dental Products Company Remineralizing and desensitizing compositions, treatments and methods of manufacture

Also Published As

Publication number Publication date
JP2017537983A (ja) 2017-12-21
MX388182B (es) 2025-03-19
AU2015361122A1 (en) 2017-06-22
EP3229792B1 (en) 2024-02-07
WO2016094054A1 (en) 2016-06-16
PL3229792T3 (pl) 2024-06-10
US20170354676A1 (en) 2017-12-14
EP3229792A4 (en) 2018-08-08
CA2970146A1 (en) 2016-06-16
US10772908B2 (en) 2020-09-15
EP3229792C0 (en) 2024-02-07
AU2015361122B2 (en) 2020-12-17
CA2970146C (en) 2023-10-31
JP6783244B2 (ja) 2020-11-11
ES2982077T3 (es) 2024-10-14
EP3229792A1 (en) 2017-10-18

Similar Documents

Publication Publication Date Title
SA517381828B1 (ar) Cftr مركبات، وتركيبات، وطرق لزيادة نشاط
EA201691911A1 (ru) Быстродействующие композиции инсулина
MX2015012334A (es) Metodos y composiciones para el control de malezas.
MX2016013826A (es) Formulaciones de peroxido y metodos y aplicaciones para utilizarlas.
TWD185242S (zh) 集成的通用串行總線裝置延長線
MX2016003414A (es) Formulaciones de adenovirus mejoradas.
MX2016011898A (es) Composiciones de compuestos selenoorganicos y metodos de uso de los mismos.
MX2018001006A (es) Composicion farmaceutica que comprende un vector adenoviral.
EA202090632A1 (ru) Способы и композиции для лечения расстройств с использованием фоллистатиновых полипептидов
PH12017500836A1 (en) Transdermal formulations
MA40460A (fr) Ciblage lysosomial et utilisation correspondante
EA201691429A1 (ru) МОДИФИЦИРОВАННЫЕ МЕНИНГОКОККОВЫЕ ПОЛИПЕПТИДЫ fHbp
MX381544B (es) Composición de células estromales mesenquimatosas para usare en el tratamiento de la sepsis en un sujeto.
MX2022005583A (es) Uso de flujo de azucar en fermentacion de etanol para producir otros productos.
EA201791174A1 (ru) Антимикотическое соединение
EP3138018A4 (en) Identifying entities to be investigated using storefront recognition
MX388182B (es) Composición para el alivio de la boca seca.
MX371443B (es) Composiciones farmaceuticas que comprenden levocetirizina.
AU2015267160A8 (en) Methods and compositions for preventing ischemia reperfusion injury in organs
MX2016003207A (es) Composiciones que comprenden colina y derivados de esta, usos de las composiciones y procesos para su preparacion.
PH12016501811B1 (en) Cosmetic composition for skin moisturizing containing minerals and quinoa extract
AU358315S (en) Novelty sconce
MX2015008586A (es) Composiciones liquidas de stevia.
GB201704788D0 (en) Improvements in or relating to the retention of liqufied natural gas on vapourisation
MX2016004333A (es) Uso de odiparcil en el tratamiento de una mucopolisacaridosis.